Report
Michael B. Schäfer

Symrise : Better organic growth of 9.5% in Q4, adj. EBITDA 2023 of € 904m, 2% below consensus, outlook fully in line with css, eyeing € 1bn adj. EBITDA - mixed

>7.9% 2023 organic sales growth better than flagged 'over 7%' in mid-December, exceeding consensus of 7.2%, good implied 9.5% organic growth in Q4 - Symrise already warned mid-December on a weaker than initially expected adj. EBITDA margin of 19-19.5%, with consensus moving to 19.4% or € 916m. Final results reported € 904m or 19.1% of sales. Today's finals show better than initially expected 'over 7%' organic sales growth in FY 2023, reporting 7.9% vs 7.2% at consensu...
Underlying
Symrise AG

Symrise AG develops, produces, and sells fragrances and flavors as well as active ingredients for the cosmetics industry. Co. operates in two main business segments: The Scent & Care segment, which develops, produces and sells fragrances, cosmetic ingredients, aroma molecules and mint aromas and also develops specific application processes for such substances; and The Flavor & Nutrition segment, which develops, produces and sells flavors that are used by customers in the production of food products (savory and sweet food products as well as dairy products) and beverages.

Provider
Oddo BHF
Oddo BHF

​Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.

Analysts
Michael B. Schäfer

Other Reports on these Companies
Other Reports from Oddo BHF

ResearchPool Subscriptions

Get the most out of your insights

Get in touch